
PacificGMP Increases Production Capacity
PacificGMP doubles its GMP production capacity with the addition of a second System 1000 Bioreactor platform.
Expansion of its operational capacity will allow PacificGMP to increase its large scale clinical manufacturing projects for its research clients, customers, and partners.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.